Kiromic Announces FDA IND Submission First-In-Human, AI derived Off-The-Shelf IsoMesothelin Gamma Delta CAR T-cell Therapy, 30 Days Before the End of the Second Quarter
Kiromic achieves key milestone for this first-in-human Phase 1 clinical trial with a target derived…
TSplus Introduces New Feedback & Roadmap Platform to Enhance the Remote Desktop User Experience
Think Business, Think Hong Kong strengthens Italy-Hong Kong ties and opens new path for Asian collaboration
FUTR Announces Q1 2026 Financial Results
Tenet Reports Third Quarter 2025 Financial Results
Eguana Announces Third Quarter 2025 Financial Results